Adipose Tissue in Breast Cancer Microphysiological Models to Capture Human Diversity in Preclinical Models
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25052728 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Katie M Hamel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Obatala Sciences, Inc., New Orleans, LA 70148, USA. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIMHD NIH HHS.
Abstract (Originalsprache)
Female breast cancer accounts for 15.2% of all new cancer cases in the United States, with a continuing increase in incidence despite efforts to discover new targeted therapies. With an approximate failure rate of 85% for therapies in the early phases of clinical trials, there is a need for more translatable, new preclinical in vitro models that include cellular heterogeneity, extracellular matrix, and human-derived biomaterials. Specifically, adipose tissue and its resident cell populations have been identified as necessary attributes for current preclinical models. Adipose-derived stromal/stem cells (ASCs) and mature adipocytes are a normal part of the breast tissue composition and not only contribute to normal breast physiology but also play a significant role in breast cancer pathophysiology. Given the recognized pro-tumorigenic role of adipocytes in tumor progression, there remains a need to enhance the complexity of current models and account for the contribution of the components that exist within the adipose stromal environment to breast tumorigenesis. This review article captures the current landscape of preclinical breast cancer models with a focus on breast cancer microphysiological system (MPS) models and their counterpart patient-derived xenograft (PDX) models to capture patient diversity as they relate to adipose tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Obatala Sciences, Inc., New Orleans, LA 70148, USA.
- Division of Basic Pharmaceutical Sciences, Xavier University of Louisiana, New Orleans, LA 70125, USA.
- Delgado Community College, New Orleans, LA 70119, USA.
- Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
ORCID-Profile: Katie M Hamel
Förderung
- NIGMS NIH HHS
- NIMHD NIH HHS
Zitieren
APA
Hamel, K. M., Frazier, T. P., Williams, C., Duplessis, T., Rowan, B. G., Gimble, J. M., & Sanchez, C. G. (2024). Adipose Tissue in Breast Cancer Microphysiological Models to Capture Human Diversity in Preclinical Models. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25052728
Vancouver
Hamel KM, Frazier TP, Williams C, Duplessis T, Rowan BG, Gimble JM, et al. Adipose Tissue in Breast Cancer Microphysiological Models to Capture Human Diversity in Preclinical Models. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25052728
BibTeX
@article{Hamel2024,
author = {Hamel, Katie M and Frazier, Trivia P and Williams, Christopher and Duplessis, Tamika and Rowan, Brian G and Gimble, Jeffrey M and Sanchez, Cecilia G},
title = {Adipose Tissue in Breast Cancer Microphysiological Models to Capture Human Diversity in Preclinical Models},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25052728}
}
EUVIMED